Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - imidacloprid - topical solution/suspension - imidacloprid guanidine active 100.0 g/l - parasiticides - cat - over 4 kg - flea - ctenocephalides spp. | flea - larvae (ctenocephalides spp.) | flea allergic dermatitis

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - imidacloprid - topical solution/suspension - imidacloprid guanidine active 100.0 g/l - parasiticides - cat - up to 4kg | kitten | young cat - flea | flea - ctenocephalides spp. | flea - larvae (ctenocephalides spp.) | flea allergic dermatitis | ctenocephalides spp. | ground fleas

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

hempel (australia) pty ltd - copper present as cuprous thiocyanate; diuron; diuron - paint - copper present as cuprous thiocyanate cyanide active 127.6 g/l; diuron urea-substituted active 62.1 g/l; diuron urea-substituted active 63.2 g/l - antifouling - boat - exterior (antifouling) - fouling - for antifouling on boats

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

jotun australia pty ltd - copper present as cuprous oxide; xylene - paint - copper present as cuprous oxide mineral-copper active 695.0 g/l; xylene solvent other 287.0 g/l - antifouling - boat - exterior (antifouling) - fouling - for antifouling on boats

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

jurox pty limited - glutaraldehyde; didecyl dimethyl ammonium chloride - aqueous concentrate - glutaraldehyde aldehyde active 124.0 g/l; didecyl dimethyl ammonium chloride ammonium-quaternary active 41.4 g/l - disinfectant - agricultural/farm buildings | animal feeder / waterer | flushing out water systems | general farm equipment | animal housing | f - general disinfection | antiviral agent | aviaries | catteries | detergent | feeding utensils | flesh wounds | floor | germicidal detergent | kennel | mastitis | mould growth | poultry cages | protozoans | stables | toilets (not septic) | walls

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

corteva agriscience australia pty ltd - fluroxypyr as the methyl heptyl ester; liquid hydrocarbon - emulsifiable concentrate - fluroxypyr as the methyl heptyl ester pyridine-pyridinoxy active 200.0 g/l; liquid hydrocarbon solvent other 586.0 g/l - herbicide - barley | commercial/industrial land | fallow or prior to seeding a crop | forest | grass pasture - established (see label) | luc - acacia genus | acacia leiocalyx (wattle) | amaranth or amaranthus | annual gooseberry | anoda weed | apple-of-peru | balsam pear | bathurst burr | bedstraw | bellvine | bellyache bush | black bindweed | blackberry nightshade | bladder ketmia | blue billygoat weed | blue heliotrope or blue top | blue snakeweed | boggabri weed | bokhara clover | brigalow | broadleaf pepper tree | brown salwood or hickory wattle | caltrop or yellow vine | centro | chinee apple | chinese celtis - seedling | cleavers | cobbler's pegs | cockspur thorn | common sensitive plant | cowpea | cowvine | deadnettle | dock | dwarf amaranth or boggabri weed | flannel weed - sida cordifolia | fumitory | giant or black pigweed | giant sensitive plant | gooseberry | green amaranth | ground or annual ground cherry | hairy wandering jew | honey locust | lablab bean | lantana - lantana camara | lantana spp. | lesser swinecress or bittercress | limebush | madeira vine | marsh or smallflower mallow | melilotus or hexham scent | milkweed | mimosa bus

New Zealand - English - Medsafe (Medicines Safety Authority)

bayer new zealand limited - estradiol hemihydrate 7.84mg equivalent to estradiol 7.59 mg (100 µg/24h) - transdermal patch - 100 mcg/24h - active: estradiol hemihydrate 7.84mg equivalent to estradiol 7.59 mg (100 µg/24h) excipient: acrylates copolymer ethyl oleate glyceryl monolaurate isopropyl myristate - for short-term treatment of complaints associated with the menopause and post-menopause, including signs and symptoms of oestrogen deficiency, whether naturally or surgically induced. oestrogen replacement therapy in women with an intact uterus should always be opposed by a progestogen in an adequate dosage regimen to ensure secretory transformation of the endometrium at regular intervals. prevention of postmenopausal osteoporosis.

New Zealand - English - Medsafe (Medicines Safety Authority)

bayer new zealand limited - estradiol hemihydrate 2.04mg equivalent to estradiol 1.97 mg (25 µg/24h) - transdermal patch - 25 mcg/24h - active: estradiol hemihydrate 2.04mg equivalent to estradiol 1.97 mg (25 µg/24h) excipient: acrylates copolymer ethyl oleate glyceryl monolaurate isopropyl myristate - for short-term treatment of complaints associated with the menopause and post-menopause, including signs and symptoms of oestrogen deficiency, whether naturally or surgically induced. oestrogen replacement therapy in women with an intact uterus should always be opposed by a progestogen in an adequate dosage regimen to ensure secretory transformation of the endometrium at regular intervals. prevention of postmenopausal osteoporosis.

New Zealand - English - Medsafe (Medicines Safety Authority)

bayer new zealand limited - estradiol hemihydrate 3.92mg equivalent to estradiol 3.79 mg (50 µg/24h) - transdermal patch - 50 mcg/24h - active: estradiol hemihydrate 3.92mg equivalent to estradiol 3.79 mg (50 µg/24h) excipient: acrylates copolymer ethyl oleate glyceryl monolaurate isopropyl myristate - for short-term treatment of complaints associated with the menopause and post-menopause, including signs and symptoms of oestrogen deficiency, whether naturally or surgically induced. oestrogen replacement therapy in women with an intact uterus should always be opposed by a progestogen in an adequate dosage regimen to ensure secretory transformation of the endometrium at regular intervals. prevention of postmenopausal osteoporosis.

New Zealand - English - Medsafe (Medicines Safety Authority)

bayer new zealand limited - estradiol hemihydrate 5.88mg equivalent to estradiol 5.69 mg (75µg/24h) - transdermal patch - 75 mcg/24h - active: estradiol hemihydrate 5.88mg equivalent to estradiol 5.69 mg (75µg/24h) excipient: acrylates copolymer ethyl oleate glyceryl monolaurate isopropyl myristate - for short-term treatment of complaints associated with the menopause and post-menopause, including signs and symptoms of oestrogen deficiency, whether naturally or surgically induced. oestrogen replacement therapy in women with an intact uterus should always be opposed by a progestogen in an adequate dosage regimen to ensure secretory transformation of the endometrium at regular intervals. prevention of postmenopausal osteoporosis.